• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

End of the story: direct-acting antiviral agents are not associated with recurrence of hepatocellular carcinoma.

作者信息

Hernaez Ruben, Thimme Robert

机构信息

Gastroenterology and Hepatology, Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas, USA

Center for Innovations in Quality, Effectiveness and Safety (IQuESt), Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas, USA.

出版信息

Gut. 2022 Mar;71(3):454-456. doi: 10.1136/gutjnl-2021-324288. Epub 2021 Mar 30.

DOI:10.1136/gutjnl-2021-324288
PMID:33785552
Abstract
摘要

相似文献

1
End of the story: direct-acting antiviral agents are not associated with recurrence of hepatocellular carcinoma.故事的结局：直接抗病毒药物与肝细胞癌复发无关。
Gut. 2022 Mar;71(3):454-456. doi: 10.1136/gutjnl-2021-324288. Epub 2021 Mar 30.
2
[Impression of direct-acting antiviral agents in the treatment of recurrent hepatocellular carcinoma related to chronic hepatitis C].
Zhonghua Gan Zang Bing Za Zhi. 2018 Mar 20;26(3):179-183. doi: 10.3760/cma.j.issn.1007-3418.2018.03.005.
3
[Hepatitis C-related hepatocellular carcinoma and the treatment with direct-acting antiviral agents].[丙型肝炎相关肝细胞癌与直接抗病毒药物治疗]
Zhonghua Gan Zang Bing Za Zhi. 2017 Dec 20;25(12):944-947. doi: 10.3760/cma.j.issn.1007-3418.2017.12.013.
4
Hepatocellular carcinoma after direct-acting antiviral hepatitis C virus therapy: A debate near the end.直接作用抗病毒治疗丙型肝炎病毒后发生的肝细胞癌：临近尾声的争议。
World J Gastroenterol. 2020 Nov 21;26(43):6770-6781. doi: 10.3748/wjg.v26.i43.6770.
5
Impact of direct-acting antivirals on early recurrence of HCV-related HCC: Comparison with interferon-based therapy.直接作用抗病毒药物对 HCV 相关 HCC 早期复发的影响：与基于干扰素的治疗比较。
J Hepatol. 2019 Jan;70(1):78-86. doi: 10.1016/j.jhep.2018.09.029. Epub 2018 Oct 16.
6
Molecular Mechanisms Involved in HCC Recurrence after Direct-Acting Antiviral Therapy.直接抗病毒治疗后 HCC 复发的分子机制。
Int J Mol Sci. 2018 Dec 22;20(1):49. doi: 10.3390/ijms20010049.
7
Hepatocellular carcinoma and direct-acting antivirals: A never ending story?肝细胞癌与直接作用抗病毒药物：一个永无止境的故事？
Liver Int. 2017 Jun;37(6):812-814. doi: 10.1111/liv.13421.
8
No differences in the risk of hepatocellular carcinoma from using direct-acting antiviral agents or interferon in patients with chronic hepatitis C: A meta-analysis.
Clin Res Hepatol Gastroenterol. 2022 Dec;46(10):102001. doi: 10.1016/j.clinre.2022.102001. Epub 2022 Aug 12.
9
Pro: Direct-acting antivirals are associated with occurrence and recurrence of hepatocellular carcinoma.专业观点：直接作用抗病毒药物与肝细胞癌的发生和复发有关。
Liver Transpl. 2017 Dec;23(12):1593-1595. doi: 10.1002/lt.24960.
10
Hepatocellular carcinoma associated with direct-acting antiviral therapy for hepatitis C virus: A report of two cases.
Rev Gastroenterol Mex (Engl Ed). 2021 Apr-Jun;86(2):197-199. doi: 10.1016/j.rgmx.2020.04.008. Epub 2020 Nov 11.

引用本文的文献

1
Outcomes and Follow-Up after Hepatitis C Eradication with Direct-Acting Antivirals.使用直接抗病毒药物根除丙型肝炎后的结果与随访
J Clin Med. 2023 Mar 12;12(6):2195. doi: 10.3390/jcm12062195.